United States · Series B startup
2 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months ago
Funding summaryUpdated 26 Oct 2026
$133Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Janus Henderson InvestorsLead
Norwest Venture Partners
Novo Holdings
Deerfield
Franklin Templeton
Invus
Platanus
4BIO Capital
Marshall Wace
MRL Ventures FundReported by 4BIO Capital
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Ray Therapeutics's investors include Norwest Venture Partners, Novo Holdings, Deerfield, Janus Henderson Investors and Franklin Templeton, and 6 more on record. Janus Henderson Investors led its latest round.
Ray Therapeutics has raised $133M across 2 rounds since 2025.
Ray Therapeutics's most recent round was a Series B of $125M in Apr 2026, led by Janus Henderson Investors.
Its most recent round, $125M in Apr 2026, is also its largest on record.
Ray Therapeutics's first round on record, in Apr 2025, was backed by Norwest Venture Partners, Novo Holdings and Deerfield.
Ray Therapeutics's latest named round is a Series B, in Apr 2026.
Ray Therapeutics is based in the United States.
Janus Henderson Investors led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
